The Food and Drug Administration warned that unapproved inhalant products containing ammonia may pose health risks.
Several unapproved inhalants being marketed to"promote alertness and boost energy" contain mostly ammonia, a toxic gas that can sometimes cause severe symptoms when inhaled, the U.S. Food and Drug Administration warned Monday .
The FDA issued its consumer safety warning after sending a letter to the products' maker, Nose Slap LLC, on April 24. The warning letter names the two stimulants being sold on the company's website, neither of which is FDA approved. According to the letter, Nose Slap and Soul Slap are advertised as energy-boosting alternatives to sugar and caffeine, and the company's website notes that both inhalants contain ammonia.
Depending on the dose inhaled, ammonia can burn the tissues of the nose, throat and windpipe; cause swelling and an accumulation of fluid in the lungs; and cause"airway destruction resulting in respiratory distress or failure," in addition to the previously listed symptoms, according to the Centers for Disease Control and Prevention . —3 men die in manure pit: Here's why it's a 'death trap.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
Alaska food banks still ‘inundated’ as state works to fix food stamp backlogAlaska food banks are inundated with demand as the state works to fix its food stamp backlog. “The anti-hunger network was not designed to replace SNAP,' said Ron Meehan, Food Bank of Alaska’s policy and advocacy manager. via AlaskaBeacon
続きを読む »
This Hot New DC Food Hall Is a Japanese Food Lover's DreamLove, Makoto opens with omakase sushi, tabletop barbecue, and an izakaya.
続きを読む »
Boxing Superstar Deontay Wilder Arrested on Gun ChargeCops reportedly searched the car after smelling marijuana on Wilder, and found a 9mm firearm along with weed.
続きを読む »
US FDA declines to approve Ascendis' hormone disorder therapyAscendis Pharma A/S said on Monday the U.S. Food & Drug Administration had declined to approve the Danish drugmaker's experimental therapy to treat adult patients with a hormone disorder called hypoparathyroidism, citing concerns linked to manufacturing control of the drug and device combination.
続きを読む »
The Newest FDA-Approved Neuromodulator Will Get Rid of 11-Lines for Six MonthsThis new Botox alternative promises results that last twice as long as its competitors. So—what do actual dermatologists think?
続きを読む »